GNIPST Bulletin 21.2

7/30/2019 GNIPST Bulletin 21.2

1/13

1

1118-1177-4796-9849-7562-5062mail

GNIPST BULLETIN 2012

28th

December 2012 Volume No.: 21 Issue No.: 0

Contents Message from GNIPS

Letter to the Editor News Update

Disease Outbreak Ne

Health Awareness

Forth Coming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

Vision

TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

PHARMACEUTICAL AND BIOLOGICAL SCIENCE

EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND

TECHNOLOGY

GNIPST Photo Gallery

For your comments/contribution

ack-Issues,

mailto:[email protected]
https://picasaweb.google.com/111714720327580099858/FreshersWelcome20122012mailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/FreshersWelcome20122012


2/13

28-12-2012

Click here to go at the top

MESSAGE FROM GNIPST

All the members of GNIPST are proud to publish the 21st

Volume

of GNIPST BULLETIN. This bulletin has successfully

completed its twenty months journey. We hope it has kept the

readers updated of recent activities in pharmaceutical & biological

sciences and also introduced them with the different activities of

our esteemed institution. We are thankful to all of you for your

great cooperation & support and are looking forward to the same in

future.

LETTER TO THE EDITOR.

NEWS UPDATE

A New Type of Nerve Cell Found in the Brain.

(21DECEMBER 2012

)An international team of scientists has identified a previously

unknown group of nerve cells in the brain. The nerve cells regulate

cardiovascular functions such as heart rhythm and blood pressure.

It is hoped that the discovery will be significant in the long term in

the treatment of cardiovascular diseases in humans. Rebuilding Blood Vessels Through Gene Therapy

(21 DECEMBER 2012)

1
http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


3/13

28-12-2012


Diagnosed with severe coronary artery disease, a group of patients

too ill for or not responding to other treatment options decided to

take part in a clinical trial testing angiogenic gene therapy to help

rebuild their damaged blood vessels.

Understanding Cell Organization to Tackle

Cancer(23 DECEMBER 2012)

Scientists have identified how cells know which way up they need

to be. The discovery could help in the fight against cancer becausein the early stages of the disease the cells become dis-organized.

New Class of Malaria Drugs Using Essential

Calcium Enzyme Developed(14 DECEMBER 2012)

Calpain, a calcium-regulated enzyme, is essential to a host of

cellular processes, but can cause severe problems in its

overactivated state, and has been implicated in several diseases.

Researchers have developed a unique approach to calpain

inhibition by mimicking a natural reaction with a synthesized

molecule.

2
http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121223152622.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121223152622.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


4/13

28-12-2012


HEALTH AWARENESS

Climate Change and Health

Climate change

Over the last 50 years, human activities particularly the burning

of fossil fuels have released sufficient quantities of carbon

dioxide and other greenhouse gases to trap additional heat in the

lower atmosphere and affect the global climate.

In the last 100 years, the world has warmed by approximately 0.750C. Over the last 25 years, the rate of global warming has

accelerated, at over 0.18 0C per decade.

Sea levels are rising, glaciers are melting and precipitation patterns

are changing. Extreme weather events are becoming more intense

and frequent.

What is the impact of climate change on health?

Although global warming may bring some localized benefits, such

as fewer winter deaths in temperate climates and increased food

production in certain areas, the overall health effects of a changing

climate are likely to be overwhelmingly negative. Climate change

affects social determinants of health clean air, safe drinking

water, sufficient food and secure shelter.

3


5/13

28-12-2012


Extreme heat

Extreme high air temperatures contribute directly to deaths from

cardiovascular and respiratory disease, particularly among elderlypeople. In the heat wave of summer 2003 in Europe for example,

more than 70 000 excess deaths were recorded.

High temperatures also raise the levels of ozone and other

pollutants in the air that exacerbate cardiovascular and

respiratory disease. Urban air pollution causes about 1.2 milliondeaths every year.

Pollen and other aeroallergen levels are also higher in extreme

heat. These can trigger asthma, which affects around 300 million

people. Ongoing temperature increases are expected to increase

this burden.

Natural disasters and variable rainfall patterns

Globally, the number of reported weather-related natural disasters

has more than tripled since the 1960. Every year, these disasters

result in over 60 000 deaths, mainly in developing countries.

Rising sea levels and increasingly extreme weather events will

destroy homes, medical facilities and other essential services. More

than half of the world's population lives within 60 km of the sea.

People may be forced to move, which in turn heightens the risk of

4


6/13

28-12-2012


a range of health effects, from mental disorders to communicable

diseases.

Increasingly variable rainfall patterns are likely to affect the supplyof fresh water. A lack of safe water can compromise hygiene and

increase the risk of diarrhoeal disease, which kills 2.2 million

people every year. In extreme cases, water scarcity leads to

drought and famine. By the 2090, climate change is likely to widen

the area affected by drought, double the frequency of extreme

droughts and increase their average duration six-fold3.

Floods are also increasing in frequency and intensity. Floods

contaminate freshwater supplies, heighten the risk of water-borne

diseases, and create breeding grounds for disease-carrying insects

such as mosquitoes. They also cause drownings and physical

injuries, damage homes and disrupt the supply of medical and

health services.

Rising temperatures and variable precipitation are likely to

decrease the production of staple foods in many of the poorest

regions by up to 50% by 2020 in some African countries4. This

will increase the prevalence of malnutrition and undernutrition,

which currently cause 3.5 million deaths every year.

Patterns of infection

5


7/13

28-12-2012


Climatic conditions strongly affect water-borne diseases and

diseases transmitted through insects, snails or other cold blooded

animals.

Changes in climate are likely to lengthen the transmission seasons

of important vector-borne diseases and to alter their geographic

range. For example, climate change is projected to widen

significantly the area of China where the snail-borne disease

schistosomiasis occurs.

Malaria is strongly influenced by climate. Transmitted by

Anopheles mosquitoes, malaria kills almost 1 million people every

year mainly African children under five years old. The Aedes

mosquito vector of dengue is also highly sensitive to climate

conditions. Studies suggest that climate change could expose an

additional 2 billion people to dengue transmission by the 2080.

Measuring the health effects

Measuring the health effects from climate change can only be very

approximate. Nevertheless, a WHO assessment, taking into

account only a subset of the possible health impacts, concluded

that the modest warming that has occurred since the 1970s was

already causing over 140 000 excess deaths annually by the year

2004.

6


8/13

28-12-2012


Who is at risk?

All populations will be affected by climate change, but some are

more vulnerable than others. People living in small islanddeveloping states and other coastal regions, megacities, and

mountainous and polar regions are particularly vulnerable.

Children in particular, children living in poor countries are

among the most vulnerable to the resulting health risks and will be

exposed longer to the health consequences. The health effects arealso expected to be more severe for elderly people and people with

infirmities or pre-existing medical conditions.

Areas with weak health infrastructure mostly in developing

countries will be the least able to cope without assistance to

prepare and respond.

DISEASE OUTBREAK NEWS

FORTHCOMING EVENTS

IPSCON-2012 45th Annual Conference of Indian Pharmacological

Society and International Conference on 'Navigating Pharmacology

towards Safe and Effective Therapy'

7


9/13

28-12-2012


Dates 04 Jan 2013 07 Jan 2013

Location: Nagpur, Maharashtra, India.

DRUGS UPDATES

FDA approves new orphan drug for rare

cholesterol disorder (26 DECEMBER 2012)

The U.S. FDA approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol,

apolipoprotein B, and non-high-density lipoprotein (non-HDL)

cholesterol in patients with homozygous familial

hypercholesterolemia (HoFH). Juxtapid is intended for use in

combination with a low fat diet and other lipid-lowering

treatments.

FDA approves Eliquis to reduce the risk of

stroke, blood clots in patients. (28 DECEMBER 2012)

The U.S. FDA approved the anti-clotting drug Eliquis (apixaban),

an oral tablet used to reduce the risk of stroke and dangerousblood clots (systemic embolism) in patients with atrial fibrillation

that is not caused by a heart valve problem.

8
http://www.ipsnagpur2012.org/http://www.ipsnagpur2012.org/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333285.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333285.htmhttp://www.ipsnagpur2012.org/


10/13

28-12-2012


CAMPUS NEWS

Two of our faculties Dr. Prerona Saha and Dr. Sriporna Kundu Sen

were awarded Ph.D (Pharmaceutical Chemistry) in the Department

of Pharmaceutical Technology, Jadavpur University, Kol-32 in the

annual convocation organized on 24th

December, 2012.

STUDENTS SECTION

WHO CAN ANSWER FIRST???() Which parasite was named after physician

and parasitologist

?

() Which is considered as ?

A) Chess B) Indian Air force

[email protected]

EDITORS NOTE

I am very happy to publish the 2nd

issue of 21st

Volume of GNIPST

BULLETIN. It is my great pleasure to introduce you to the newly

9
mailto:[email protected]:[email protected]:[email protected]


11/13

28-12-2012


launched facebook account GNIPST bulletin. You are cordially

invited to add this account to your friend list. The current issues will

also be directly available on facebook.

I would like to convey my thanks to all the GNIPST members and

the readers for their valuable comments, encouragement& supports.

Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya

Bhattacharya, for his contribution in students section.

It would be my great pleasure to receive the contributions,

suggestions & feedback from your desk for further upliftment of thisdeliberation GNIPST BULLETIN.

ARCHIVE

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15

th

June, 2012. The programme startedwith a nice presentation by Dr. Pulok Kr. Mukherjee, School of

Natural Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm) in

The approved number of seat is 18.

10


12/13

28-12-2012


The number of seats in B.Pharm. has been increased from 60 to

120.

2

nd

World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and

Dosimetry (SWC-2013) : On the Way to Personalized Medicine

Dates 28 Feb 2013 02 Mar 2013

Location: Chandigarh, India.

5-Days Hands-on Workshop on Molecular Biotechnology and Bioinformatics.

7thto 11th January 2013, Pune, Maharashtra, India.

IAMLE- 2013 4th International Conference on Medical Negligence and

litigation in Medical Practice, and 4th International Conference on Recent

Advances in Forensic Sciences, Forensic Medicine & Toxicology.

Date: 25 Jan 2013 27 Jan 2013, Location: Kovalam, Thiruvanthapuram,

India.

will be held from

, at Chennai. The four-day event will be

organized by the Association of Pharmacy Teachers of India (APTI).

11
http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.icsccb.org/workshops/http://www.icsccb.org/workshops/http://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.icsccb.org/workshops/http://www.2ndworldcongress-ga-68.de/


13/13

28-12-2012


AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-

13 to GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of

Pharmaceutical Science & Technology.

b. Principal Investigator: Dr. Lopamudra Dutta.

c. Grant-in-aid sanctioned: Rs. 16,25000/- only

d.Approved duration: 3 years

e. Title of the project: Screening and identification of

potential medicinal plant ofPurulia & Bankura districts of West

Bengal with respect to diseases such as diabetes, rheumatism,

Jaundice, hypertension and developing biotechnological tools for

enhancing bioactive molecules in these plant.

Special classes on Communication Skills, G.D. and

Interview will commence from 3rd week of January 2013

for the students of this Institute. Interested students are

required to contact the undersigned for enrolment either

personally or by e-mail.

Dr. Lopamudra Datta

E-mail: [email protected]

[email protected]

12
mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]

GNIPST Bulletin 21.2

Documents

Transcript of GNIPST Bulletin 21.2